Be the first to like this
LifeTech Capital Updates NeoStem (NBS) Strong Buy $4.00 Target. New York, NY-based NeoStem is a multi-faceted, multinational medical company. Among their business are adult stem cell collection, processing and storage in the U.S., research and development for diagnostic and therapeutic applications using autologous adult stem cells, including their VSEL™ technology (very small embryonic-like stem cells) and several China-based, adult stem cell therapeutics operational and R&D activities for adult stem cell therapeutics focused on regenerative medicine. In addition, NeoStem and the Vatican's Pontifical Council for Culture announced a joint initiative with their charitable foundations to expand research and raise awareness of adult stem cell therapies. A 3-day international conference at the Vatican on adult stem cell research, including VSEL™ technology, is planned for 2011 and will focus on medical research presentations and theological and philosophical considerations and implications of scientific achievements.